A poll lists top health issues in battleground states; no COVID-19 vaccine has been tested on children; researchers find a more contagious COVID-19 strain.
As the 2020 election season heats up, voters in battleground states listed coronavirus disease 2019 (COVID-19) and protecting insurance for individuals with preexisting conditions as the top health issues influencing their vote. The poll, conducted by The Commonwealth Fund, surveyed nearly 7500 individuals in 10 battleground states between mid-August and mid-September. Forty percent of respondents said addressing the public health needs and economic costs of COVID-19 was a priority, whereas 39% listed ensuring coverage for those with preexisting conditions as a top concern. Another 20% of voters said lowering the cost of health care was the most important health issue affecting their vote.
Despite numerous trials being carried out to test a COVID-19 vaccine, none of the trial populations include children, prompting concern in some experts who worry about the timeline for making the vaccine available to kids, Business Insider reports. Leading experimental vaccines are now in the final stages of clinical trials and some results are expected as early as next month. Although Pfizer, Moderna, AstraZeneca, and Johnson & Johnson all plan to test their vaccines on children, none have provided a timeline on when such a shot would be available. Leaders of Operation Warp Speed, the US government’s vaccine initiative, have not laid out or mentioned a plan for vaccinating children over the past few months.
A study conducted by researchers at Houston Methodist Hospital found that a more contagious strain of COVID-19 dominates recent coronavirus samples, Reuters reports. The study, which analyses the structure of the novel coronavirus from 2 waves of infection in Houston, included examination of more than 5000 genomes from viruses recovered in the earliest phase of the pandemic. It also includes samples from an ongoing more recent wave of infections. The study has yet to be reviewed by outside experts. According to research, nearly all strains in the second wave had a mutation, D614G, which is known to increase the number of “spikes” on the crown-shaped virus, allowing the virus to bind to and infect more cells.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Eliminating Enhanced PTCs Would Have Cascading Economic Impacts, Report Estimates
March 6th 2025Enhanced premium tax credits (PTCs) have made marketplace health insurance more affordable, and eliminating them could have sweeping impacts on consumers and the health care industry, according to a new report.
Read More